Allogene Therapeutics, Inc.
ALLO · Healthcare · $552M
$1.60-1.23%
Price
$2.08
$1.62
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$0M-99.9%
6/'26 vs prev quarter
Company Health
Market Cap$552M
Operating Margin-3886.1%
Cash on Hand$333M60.2% of market cap
Free Cash Flow$-103M-18.6% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR119.0xmedian 11.4xPBR1.3xmedian 2.0xROE-37.9%median -54.5%
